Equity Capital Markets

Company · CIK 1521036

Lantheus Holdings, Inc.

CIK1521036 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inDE
Business addressMA
ListedLNTH (Nasdaq)
First annual or quarterly report2015-08-05

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-215055
ShelfEffective
 2016-12-122017-03-133
333-212940
ShelfEffective
 2016-08-052016-11-176
333-196998
IPOFinal prospectus
 2014-06-242015-06-2612

Filings

23
FiledFilingRegistrationAccession
2020-03-18EFFECTDeclared effective 333-2346279999999995-20-000583
2017-03-13424B5Shelf takedown 333-2150550001193125-17-080429
2017-01-04EFFECTDeclared effective 333-2150559999999995-17-000024
2016-12-12S-3Shelf registered 333-2150550001193125-16-790867
2016-11-17424B5Shelf takedown 333-2129400001193125-16-771017
2016-11-16424B5Shelf takedown 333-2129400001193125-16-769127
2016-09-12424B5Shelf takedown 333-2129400001193125-16-707553
2016-09-08424B5Shelf takedown 333-2129400001193125-16-705210
2016-08-31EFFECTDeclared effective 333-2129409999999995-16-005556
2016-08-05S-3Shelf registered 333-2129400001193125-16-673463
2015-06-26424B4Final prospectus 333-1969980001193125-15-237057
2015-06-24EFFECTDeclared effective 333-1969989999999995-15-001716
2015-06-16S-1/AAmendment 333-1969980001193125-15-223914
2015-06-08S-1/AAmendment 333-1969980001193125-15-216475
2015-03-18S-1/AAmendment 333-1969980001193125-15-095651
2014-12-19S-1/AAmendment 333-1969980001193125-14-448655
2014-11-07S-1/AAmendment 333-1969980001193125-14-403394
2014-08-11S-1/AAmendment 333-1969980001193125-14-304822
2014-07-24S-1/AAmendment 333-1969980001193125-14-278700
2014-07-17S-1/AAmendment 333-1969980001193125-14-270597
2014-07-09S-1/AAmendment 333-1969980001193125-14-264353
2014-06-24S-1Registration filed 333-1969980001193125-14-247341
2014-03-25DRSDraft made public 377-005310000950123-14-003311

All filings of this company · CSV